Healthcare / Medical Care FacilitiesNYSE
$106.10
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF n/d · quality 50.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
20/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$10.5B
P/E
N/A
•EV/EBITDA
N/A
•ROE
23.2%
↑Gross Margin
N/A
•Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
—
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.94B · net income $566.2M · FCF —
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $5.94B | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B | — | — | — | — | — | — | — | — |
| Net Income | $566.2M | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M | $284.2M | $358.7M | $292.3M | $271.1M | $247.6M | $183.1M | $222.0M | $323.6M | $185.0M | $208.7M | $899.0M | $94.8M | $252.4M |
| EBITDA | — | — | — | — | $783.1M | $779.2M | $766.9M | $830.8M | $754.9M | $762.1M | $760.7M | $625.4M | — | — | — | — | — | — | — |
| EPS | 5.54 | 5.54 | 4.46 | 3.47 | 2.70 | 4.11 | 2.85 | 3.61 | 2.93 | 2.84 | 2.59 | 1.91 | 2.29 | 2.58 | 1.67 | 1.96 | 8.28 | 0.77 | 2.62 |
| Operating Margin | — | — | — | — | 12.4% | 13.9% | 15.8% | 13.3% | 13.0% | 14.8% | 16.1% | — | — | — | — | — | — | — | — |
| Net Margin | 9.5% | 9.5% | 8.5% | 7.3% | 6.2% | 10.3% | 8.0% | 7.8% | 6.8% | 6.9% | 6.8% | — | — | — | — | — | — | — | — |
| Balance Sheet | |||||||||||||||||||
| Debt/Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 10.56 | -17.57 | -1.83 | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | — | — | — | — | $141.0M | $191.2M | $311.9M | $262.9M | $507.9M | $432.5M | $462.5M | $373.6M | $274.0M | $275.1M | $270.7M | $242.4M | $268.2M | $342.8M | $171.5M |
| Returns | |||||||||||||||||||
| ROE | 23.2% | 23.2% | 22.0% | 21.4% | 20.7% | 21.6% | 17.9% | 26.5% | 22.9% | 23.5% | 33.6% | 29.9% | 46.9% | 93.9% | 63.6% | 178.4% | -1055.2% | -10.6% | -23.2% |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | 10.5% | 10.5% | 11.9% | 10.4% | 8.3% | 12.6% | -22.6% | 7.7% | 9.3% | 7.4% | — | — | — | — | — | — | — | — | — |
| EPS Growth | 24.2% | 24.2% | 28.5% | 28.5% | -34.3% | 44.2% | -21.1% | 23.2% | 3.2% | 9.7% | 35.6% | -16.6% | -11.2% | 54.5% | -14.8% | -76.3% | 975.3% | -70.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.3%
EPS terminal req.
$9.41
Spread vs growth
4.9%
5Y implied EPS CAGR
15.5%
EPS terminal req.
$11.39
Spread vs growth
8.7%
10Y implied EPS CAGR
12.7%
EPS terminal req.
$18.35
Spread vs growth
11.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.